Mayim Bialik has described her experience with GLP-1 weight-loss drugs as a “nightmare” in a new essay, saying she took the medication for medical reasons but developed severe side effects that forced her to stop. In the Free Press essay “My GLP-1 Nightmare,” published Friday, the actress wrote that she had lived with scrutiny over her body since adolescence, first as a teenage star on NBC’s “Blossom” and later as a public figure whose appearance was closely watched. She said those pressures, combined with medication-related weight gain in her teens and the rise of social media, contributed to a difficult and long-running relationship with food and body image. Bialik, 50, said early menopause added more weight, but she emphasized that her decision to try a GLP-1 drug was not primarily about losing those pounds.
She explained that doctors recommended the treatment to help with symptoms tied to several health conditions, including Graves’ disease, Sjögren’s syndrome, dysautonomia, connective tissue disease and mast cell activation syndrome. According to Bialik, three different doctors suggested the drug because GLP-1 medications may help reduce systemic inflammation linked to autoimmune disorders. She said she briefly hoped the medication could be a turning point, but after taking one injection of the lowest dose, she experienced intense gastrointestinal and physical reactions. Among the symptoms she described were uncontrollable diarrhea, severe sulfur burps, sneezing attacks when trying to eat or drink, cramping, bloating, and body aches that felt like the flu.
Bialik wrote that the effects were so strong she struggled to keep down water and sometimes could not reach the bathroom in time. She said the drug’s long half-life meant the symptoms lingered, and her doctor warned her that the reaction could last at least a week or more. After the experience, she said her body “made its position clear,” and she decided to stop taking the medication. She then saw a gastroenterologist, who reportedly told her GLP-1 drugs are highly disruptive and should be reserved for serious medical situations, especially life-threatening obesity and its related complications. Bialik said that assessment made her feel validated and reassured that the reaction was real, not imagined.
In the essay’s closing, Bialik said that after leaving the appointment she glanced at her reflection and felt unexpectedly calm rather than distressed. She wrote that she noticed a change in how she viewed herself, describing a moment of acceptance after months of fixation on her appearance. Bialik’s account adds to growing public discussion about GLP-1 medications, which have become widely used for weight loss but have also drawn attention for side effects and cautionary stories shared by other celebrities.
